MODIQUEST B V has a total of 35 patent applications. It increased the IP activity by 200.0%. Its first patent ever was published in 2005. It filed its patents most often in United States, EPO (European Patent Office) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are GENSCI REGENERATION SCIENCES I, INFLARX GMBH and XOMA US LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | EPO (European Patent Office) | 7 | |
#3 | Canada | 4 | |
#4 | WIPO (World Intellectual Property Organization) | 4 | |
#5 | Australia | 3 | |
#6 | China | 2 | |
#7 | United Kingdom | 2 | |
#8 | Republic of Korea | 2 | |
#9 | Brazil | 1 | |
#10 | EAPO (Eurasian Patent Organization) | 1 | |
#11 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Organic fine chemistry | |
#5 | Chemical engineering | |
#6 | Textiles and paper |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Peptides | |
#3 | Medical preparations | |
#4 | Chemical or physical processes | |
#5 | Paper coating | |
#6 | Combinatorial chemistry | |
#7 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Raats Jozef Maria Hendrik | 30 |
#2 | Chirivi Renato Gerardus Silvano | 25 |
#3 | Roodink Ilse | 3 |
#4 | Leenders Wilhelmus Petrus Johannes | 3 |
#5 | Chirivi Mr Renato Gerardus Silvano | 1 |
#6 | Hof Danielle | 1 |
#7 | Chirivi Renato Geradus Silvano | 1 |
#8 | Van Hest Jan Cornelis Maria | 1 |
#9 | Raats Mr Jozef Maria Hendrik | 1 |
#10 | Van Rosmalen Johannes Wilhelmus Gerardus | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020038963A1 | Antibodies binding to citrullinated histone 2a and/or 4 | |
GB201900983D0 | Antibody | |
GB201813597D0 | Antibody | |
AU2015359262A1 | Method for the treatment of idiopathic pulmonary fibrosis | |
EP2532639A1 | Method for preparing a reactive coating | |
EP2332987A1 | Anti-inflammatory agents directed against citrullinated epitopes | |
KR20110015035A | Anti-inflammatory agents | |
WO2006049498A1 | Means and methods for isolating and/or identifying a target molecule |